Articles By Anuja Singh
Is Exscientia Setting the Financial Benchmark for AI Drug Discovery with $6B+ in Pharma…
Strategic Insights Exscientia has emerged as one of the most financially validated AI-drug discovery companies, translating computational precision…
ByIs Insilico Medicine Redefining Drug Discovery as AI Becomes Core to Biopharma Strategy?
Executive Summary Insilico Medicine has emerged as one of the most influential AI-native biotechnology companies, reshaping how the…
Can Vanda Pharma’s FDA Approval of Nereus Unlock a New Growth Chapter in Motion-Sickness…
New York | Jan, 2026 — Vanda Pharmaceuticals Inc. achieved a major regulatory and commercial milestone after the…
Can Bristol Myers Squibb’s $330 Million AI Investment in 2025 — Powered by Strategic…
Global – December 31, 2025 — Bristol Myers Squibb (BMS) significantly expanded its commitment to artificial intelligence (AI)…
Can GSK’s $340 Million AI Investment in 2025 — Backed by Strategic Collaborations —…
Global – December 31, 2025 — GlaxoSmithKline plc (GSK) significantly expanded its use of artificial intelligence (AI) throughout…
Can AstraZeneca’s $390 Million AI Investment in 2025 — Fueled by Strategic Partnerships —…
Global – December 31, 2025 — AstraZeneca plc significantly expanded its commitment to artificial intelligence (AI) throughout 2025,…
Is Exscientia Setting the Financial Benchmark for AI Drug Discovery with $6B+ in Pharma…
Strategic Insights Exscientia has emerged as one of the most financially validated AI-drug discovery companies, translating computational precision…
Is Insilico Medicine Redefining Drug Discovery as AI Becomes Core to Biopharma Strategy?
Executive Summary Insilico Medicine has emerged as one of the most influential AI-native biotechnology companies, reshaping how the…
Can Vanda Pharma’s FDA Approval of Nereus Unlock a New Growth Chapter in Motion-Sickness…
New York | Jan, 2026 — Vanda Pharmaceuticals Inc. achieved a major regulatory and commercial milestone after the…
Can Bristol Myers Squibb’s $330 Million AI Investment in 2025 — Powered by Strategic…
Global – December 31, 2025 — Bristol Myers Squibb (BMS) significantly expanded its commitment to artificial intelligence (AI)…
Can GSK’s $340 Million AI Investment in 2025 — Backed by Strategic Collaborations —…
Global – December 31, 2025 — GlaxoSmithKline plc (GSK) significantly expanded its use of artificial intelligence (AI) throughout…
Can AstraZeneca’s $390 Million AI Investment in 2025 — Fueled by Strategic Partnerships —…
Global – December 31, 2025 — AstraZeneca plc significantly expanded its commitment to artificial intelligence (AI) throughout 2025,…